4021 — Nissan Chemical Balance Sheet
0.000.00%
- ¥563bn
- ¥585bn
- ¥227bn
- 97
- 52
- 41
- 72
Annual balance sheet for Nissan Chemical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 30,639 | 32,380 | 34,658 | 29,647 | 22,738 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 77,293 | 77,663 | 84,303 | 87,827 | 93,860 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 154,196 | 159,588 | 175,279 | 189,454 | 201,968 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 51,581 | 51,837 | 53,177 | 64,653 | 77,372 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 249,522 | 265,509 | 279,687 | 298,715 | 323,458 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 60,015 | 59,744 | 65,971 | 72,161 | 86,563 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 65,604 | 66,680 | 73,775 | 80,296 | 95,987 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 183,918 | 198,829 | 205,912 | 218,419 | 227,471 |
Total Liabilities & Shareholders' Equity | 249,522 | 265,509 | 279,687 | 298,715 | 323,458 |
Total Common Shares Outstanding |